Delivery Order SPE2DB22D3011-SPE2DB25FQ1UJ
- Not listed
- The Defense Logistics Agency awarded a $5,299.78 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $5,307.30 firm fixed price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The place of performance is AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a $7,797.87 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The contract is scheduled for completion by July 23, 2025, reflecting the expedited nature of this pharmaceutical procurement. This...
- The Defense Logistics Agency awarded a $15,872.15 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 15, 2025, with completion expected by September 16, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $25,277.89 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 9, 2025, with a completion date of September 10, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,404.62 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units). This firm fixed-price, competitively awarded delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $3,354.92 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on July 30, 2025, with a completion date of July 31, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a pharmaceutical supply delivery to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $15,281.01 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion deadline of July 31, 2025. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $4,254.60 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on August 13, 2025, with completion targeted for August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $26,128.50 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units). This non-set-aside, firm fixed-price delivery order was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement fulfilling the Defense Health...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ1UJDelivery Order
The Defense Logistics Agency awarded a $17,506.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units) on July 16, 2025, with completion scheduled for July 17, 2025. This non-competitive delivery order represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters and primary operations center. This delivery order is issued under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a prime vendor vehicle supporting the Defense Health Agency and other military healthcare systems with a global scope of pharmaceutical supply. AmerisourceBergen's federal contract portfolio demonstrates its established capacity to supply diverse pharmaceutical products across multiple therapeutic categories, with this order contributing to the company's ongoing role as a critical pharmaceutical distributor for military and federal healthcare operations.